Back to search
FDAFDA · Food and drugs·Recall number D-1036-2017

Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15

Published August 9, 2017 · Recall initiated: June 19, 2017

Summary

FDA records drug Class II recall D-1036-2017, published August 9, 2017 and initiated June 19, 2017. Recalling firm: Apace KY LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot: 16710, exp 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apace KY LLC
Distributor
KY
Lot
Lot: 16710, exp 07/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15 recalled?

Yes. FDA published recall D-1036-2017 on August 9, 2017. Reported hazard: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail